Edition:
United Kingdom

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

3.67USD
16 Aug 2019
Change (% chg)

$0.23 (+6.69%)
Prev Close
$3.44
Open
$3.47
Day's High
$3.67
Day's Low
$3.47
Volume
140,405
Avg. Vol
352,392
52-wk High
$9.28
52-wk Low
$1.87

Latest Key Developments (Source: Significant Developments)

Amyris Receives A Notice Of Acceleration From Investor With Respect To CVI Note
Friday, 19 Jul 2019 

July 19 (Reuters) - Amyris Inc ::AMYRIS INC - ON JULY 12, COMPANY RECEIVED A NOTICE OF ACCELERATION FROM INVESTOR WITH RESPECT TO CVI NOTE.AMYRIS - NOTICE WAS PROVIDED IN CONNECTION WITH COMPANY S FAILURE TO MAKE AN INSTALLMENT PAYMENT ON CVI NOTE DUE JULY 1, 2019 IN AMOUNT OF $6.4 MILLION.AMYRIS - COMPANY HAD UNTIL JULY 19, 2019 TO REPAY ALL AMOUNTS OUTSTANDING UNDER CVI NOTE, REPRESENTING AN AGGREGATE AMOUNT OF APPROXIMATELY $68.0 MILLION.AMYRIS INC - ON JULY 19, 2019, CVI REVOKED AND WITHDREW ACCELERATION NOTICE PRIOR TO DEADLINE FOR COMPANY TO REPAY CVI NOTE.AMYRIS INC - COMPANY AND CVI ARE CURRENTLY IN PROCESS OF FINALIZING AND DOCUMENTING A RESOLUTION TO PAYMENT DEFAULT..  Full Article

Amyris Announces The Execution Of Strategic Supply Agreements With Raízen, The Largest Sugar Producer In The World
Tuesday, 21 May 2019 

May 21 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES THE EXECUTION OF STRATEGIC SUPPLY AGREEMENTS WITH RAÍZEN, THE LARGEST SUGAR PRODUCER IN THE WORLD.AMYRIS INC - ENTERED ARRANGEMENT TO ESTABLISH BASIS FOR POTENTIAL JOINT VENTURE BETWEEN AMYRIS & RAÍZEN.  Full Article

Amyris Retires May 2019 Convertible Note Debt
Wednesday, 15 May 2019 

May 15 (Reuters) - Amyris Inc ::AMYRIS RETIRES MAY 2019 CONVERTIBLE NOTE DEBT.AMYRIS INC - SUCCEEDED IN RETIRING $87 MILLION OF CONVERTIBLE DEBT THIS YEAR.AMYRIS INC - RETIRED ITS 6.5% CONVERTIBLE NOTES DUE MAY 2019.AMYRIS INC - ONE OF NOTEHOLDERS, BOARD-AFFILIATED TOTAL S.A. REQUESTED EXTENSION & CO PAID THIS PORTION WITH NEW NOTE PAYABLE TO TOTAL.  Full Article

Temasek Holdings (Private) Ltd Dissolves Share Stake In Tencent Music, Gilead Sciences; Cuts in Alibaba
Wednesday, 15 May 2019 

May 15 (Reuters) - Temasek Holdings (Private) Ltd::TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN TENCENT MUSIC ENTERTAINMENT GROUP - SEC FILING.TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN GILEAD SCIENCES INC.TEMASEK HOLDINGS (PRIVATE) LTD CUTS SHARE STAKE IN ALIBABA GROUP HOLDING LTD BY 4.7 PERCENT TO 26.1 MILLION SPONSORED ADSS.TEMASEK HOLDINGS (PRIVATE) LTD CUTS SHARE STAKE IN FARFETCH LTD BY 27.2 PERCENT TO 3.3 MILLION CLASS A ORDINARY SHARES.TEMASEK HOLDINGS (PRIVATE) LTD TAKES SHARE STAKE OF 167,620 SHARES IN SVMK INC.TEMASEK HOLDINGS (PRIVATE) LTD TAKES SHARE STAKE OF 442,021 SHARES IN AMYRIS INC.TEMASEK HOLDINGS (PRIVATE) LTD - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2019 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DECEMBER 31, 2018.  Full Article

Amyris Q4 Loss Per Share $1.03
Monday, 18 Mar 2019 

March 18 (Reuters) - Amyris Inc ::AMYRIS REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS AND ANNOUNCES SIGNING OF $300 MILLION DEFINITIVE CANNABINOID AGREEMENT.Q4 GAAP LOSS PER SHARE $1.03.Q4 REVENUE $19.4 MILLION VERSUS $80.6 MILLION.AGREED ON A CLEAR PATH FORWARD FOR VITAMIN E ROYALTY.SIGNED $300 MILLION DEFINITIVE CANNABINOID AGREEMENT WITH LAVVAN, INC..QTRLY NEGATIVE RESULTS AND FY REFLECT INABILITY TO RECOGNIZE REVENUE FOR A $50 MILLION MULTI-PARTY VITAMIN E DEAL IN CHINA.QTRLY ADJUSTED BASIC EARNINGS PER SHARE $0.76.  Full Article

Amyris Finalizes Cannabinoid Agreement
Monday, 18 Mar 2019 

March 18 (Reuters) - Amyris Inc ::AMYRIS FINALIZES CANNABINOID DEVELOPMENT, LICENSING AND COMMERCIALIZATION AGREEMENT CONTAINING $300 MILLION OF RESEARCH AND DEVELOPMENT AND MILESTONE PAYMENTS AND A LONG-TERM ROYALTY STREAM.AMYRIS - DEAL FOR CANNABINOID DEVELOPMENT, LICENSING, COMMERCIALIZATION CONTAINING $300 MILLION OF RESEARCH AND DEVELOPMENT AND MILESTONE PAYMENTS PLUS LONG-TERM ROYALTIES.AMYRIS INC - AMYRIS BELIEVES IT CAN EARN A SIGNIFICANT PORTION OF THESE MILESTONE PAYMENTS BY END OF 2020.AMYRIS INC - LAVVAN WILL BE RESPONSIBLE FOR GLOBAL MANUFACTURE AND COMMERCIALIZATION OF CANNABINOIDS.  Full Article

Amyris Reports Q3 Revenue $14.9 Million
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Amyris Inc ::AMYRIS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 GAAP LOSS PER SHARE $1.67.Q3 REVENUE $14.9 MILLION VERSUS $24.2 MILLION.  Full Article

Amyris Expects To Resume Full Production Of Its Squalane Product For Customers
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Amyris Inc ::AMYRIS PROVIDES UPDATE ON LELAND, NC PRODUCTION FACILITY.AMYRIS INC - EXPECTS TO RESUME FULL PRODUCTION OF ITS SQUALANE PRODUCT FOR CUSTOMERS WITHOUT ANY IMPACT TO ITS Q3 OR FULL YEAR SQUALANE RESULTS.AMYRIS INC - FLORENCE HURRICANE DOES NOT APPEAR TO HAVE CAUSED ANY MATERIAL DAMAGE TO PROCESS EQUIPMENT OR INVENTORY.AMYRIS INC - EXPECTS A QUICK RETURN TO FULL PRODUCTION ONCE POWER IS RESTORED AND PLANT IS BACK ONLINE.AMYRIS INC - ASSESSMENTS OF IMPACT OF FLORENCE CONTINUE.  Full Article

Amyris Reports Q2 Loss Per Share Of $0.32
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Amyris Inc ::AMYRIS DELIVERS ANOTHER QUARTER OF PROFITABLE GROWTH WHILE EXECUTING WELL ON STRATEGIC AGENDA.Q2 NON-GAAP LOSS PER SHARE $0.38.Q2 GAAP LOSS PER SHARE $0.32.Q2 REVENUE $24.8 MILLION VERSUS $25.7 MILLION.  Full Article

Amyris Says Novvi LLC and Chevron Entered Agreement
Friday, 18 May 2018 

May 18 (Reuters) - Amyris Inc ::AMYRIS SUSTAINABLE LUBRICANTS JOINT VENTURE COMPANY, NOVVI, AND CHEVRON ENTER AGREEMENT TO DEVELOP AND BRING TO MARKET NEW RENEWABLE BASE OIL TECHNOLOGIES.AMYRIS INC - TERMS OF TRANSACTION WERE NOT DISCLOSED.AMYRIS INC - NOVVI LLC AND CHEVRON ENTERED INTO AGREEMENT TO JOINTLY DEVELOP AND BRING TO MARKET NOVEL RENEWABLE BASE OIL TECHNOLOGIES.  Full Article